Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER AF) study. The study is evaluating the AcQMap High Resolution Imaging and Mapping System in patients with persistent atrial fibrillation (AF) in Europe and Canada.

CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in the peer-reviewed journal, The American Journal of Medicine.

The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on April 29 to address the need to standardize best practices in cardiac surgery. The session, titled “ERACS: Best Practices, Cost-Effective Initiative,” featured a consortium of forward-thinking leaders in cardiac surgery joining together as other specialties have done through their Enhanced Recovery After Surgery (ERAS) programs.


Cardiac ultrasound technology is undergoing an automation technology transformation similar to that seen with computed tomography (CT) advanced visualization software over the past decade. For years, echocardiography software tools like strain and 3-D assessment have existed to help in cardiac quantification, but the technology required numerous steps, was time-consuming and often had to be done on a separate workstation. Additionally, there was wide variability in how the exams were scanned and how measurements were taken based on user experience.


May 2, 2017 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Teleflex Inc. AC3 Optimus Intra-Aortic Balloon Pump (IABP). The device helps augment a weakened heart’s ability to pump blood. This includes a broad range of patients, including those not previously considered candidates for IABP therapy. Clinicians may use the pump on patients with the most severe arrhythmias or with heart rates as high as 200 beats per minute.[1,2]


May 2, 2017 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of April based on website analytics of the month’s 105,000 pageviews:  

1. FDA Harshly Criticizes Abbott, St. Jude For Failure to Address EP Device Safety


Conavi Medical Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Foresight ICE (intracardiac echo) System expanded feature set. The enhancements include color doppler, pulsed wave doppler, 2-D and 3-D measurements, and electrocardiogram (ECG)-gated 3-D image acquisition. These enhancements are expected to help electrophysiologists and interventional cardiologists in the United States by providing them with the tools to make decisions during minimally invasive cardiovascular procedures.

ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The award was presented to ClearFlow for its development of the PleuraFlow Active Clearance Technology (ACT) System, which has been clinically shown to reduce the occurrence of complications after cardiac surgery, according to the company.

Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous coronary intervention (PCI) procedure using the CorPath GRX System to more than 4,000 attendees at the 22nd annual TCT Asia-Pacific Cardiovascular Summit.

Having a non-O blood group is associated with a higher risk of heart attack, according to research presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France.

Subscribe Now